publication date: Oct. 9, 2020
Issue 38 - Oct. 9, 2020
  • First-ever TCL-AACI study of the leadership pipeline points to urgent need for more diversity at elite cancer centers

    How diverse are the upper rungs of leadership at America’s academic cancer centers?

    Are these institutions promoting women and underrepresented minorities into top leadership positions? How prevalent are diversity recruitment programs? Do they work?

  • Guest Editorial

    A long road ahead but every reason to travel with purpose

    Diversity, inclusion, and equity are important issues, not only to our nation’s cancer centers, but to our nation as a whole. To embody these values, we must work to close gaps in cancer research and care.

  • “We can’t let this issue slide into the background.”

    Directors of cancer centers reflect on the TCL-AACI data

    If we’re not diverse enough, we will lose the opportunity to learn something from the differences among us,” Rohit Bhargava, director, Cancer Center at Illinois at the University of Illinois Urbana-Champaign, said to The Cancer Letter. “It may not come out from the commonalities among us, and those differences might hold the key to actually developing new approaches for everyone.

  • Guest Editorial

    ASCO survey demonstrates views on cancer care amid COVID-19 and racial reckoning

    Last week, a national public perception survey from the American Society of Clinical Oncology revealed a public grappling with cancer care amid the COVID-19 pandemic and the nation’s reckoning with racial injustice.

  • NCI awards 25 grants and contracts as part of SeroNet

    NCI has awarded 25 grants and contracts as part of the Serological Sciences Network initiative.

  • 2020 Nobel Prizes

    • Jennifer A. Doudna and Emmanuelle Charpentier receive 2020 Nobel Prize in Chemistry
    • Harvey J. Alter, Michael Houghton and Charles M. Rice receive the 2020 Nobel Prize in Physiology or Medicine for the discovery of hepatitis C virus
  • In Brief

    • Kelvin Lee named director of IU Melvin and Bren Simon Comprehensive Cancer Center
    • Jan Kitajewski named director of the University of Illinois Cancer Center
    • Ira Pastan receives Paul A. Volcker Career Achievement Medal
    • Thomas J. Fuchs named dean of artificial intelligence and human health, co-director of Hasso Plattner Institute for Digital Health at Mount Sinai
    • Kevin Kalinsky named director of Glenn Family Breast Center at Winship
    • David Gius named associate cancer center director for translational research at Mays Cancer Center
    • Sarasota Memorial Cancer receives $25 million from Brian and Sheila Jellison Family Foundation
    • Yale’s Sidi Chen receives $500,000 ACGT grant for pancreatic cancer research
    • City of Hope forms AccessHope for employers to improve care, experience, outcomes and value


  • TCCL Logo

  • Trials & Tribulations

    Overcoming systemic barriers to improve cancer clinical trials

    One of the more complex tasks that I performed in my medical oncology practice was enrolling patients on a clinical trial.

  • Clinical Roundup

    • City of Hope leads novel clinical trial to treat cancer patients with COVID-19
    • Novel CAR T-cell lymphoma therapy developed at MCW advances to phase II study
    • MD Anderson researchers identify characteristics of infused CAR T cells associated with efficacy and toxicity in large B-cell lymphoma
    • MD Anderson researchers: Cancer mutations accumulate in distinct regions based on structure of genome and mutational causes
    • UCSD study: Personalized cancer therapy improves outcomes in advanced disease
    • Phase III CheckMate-816 trial: Opdivo + chemotherapy demonstrates improvement in pathologic CR in resectable NSCLC
  • Drugs & Targets

    • Opdivo + Yervoy receive FDA approval in mesothelioma indication
    • Regeneron asks FDA for emergency clearance for COVID-19 therapy
    • FDA issues draft guidance that encourages inclusion of premenopausal women in breast cancer clinical trials

Copyright (c) 2020 The Cancer Letter Inc.